Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
381 SUPLEXA, a multimodal autologous cellular therapy, shows immunomodulatory behavior in cancer patients consistent with improved anti-tumor immune function
Compose a Response to This Article
Other responses
No responses have been published for this article.
